Israel Englander’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57.7M Buy
2,541,109
+261,658
+11% +$5.99M 0.02% 813
2026
Q1
$53.1M Buy
2,279,451
+669,146
+42% +$14.4M 0.02% 790
2025
Q4
$32.2M Sell
1,610,305
-31,010
-2% -$606K 0.01% 1129
2025
Q3
$30M Sell
1,641,315
-348,037
-17% -$6.79M 0.01% 1265
2025
Q2
$40M Buy
1,989,352
+313,295
+19% +$6.03M 0.02% 968
2025
Q1
$30.4M Buy
1,676,057
+1,275,444
+318% +$22.9M 0.02% 1145
2024
Q4
$6.95M Buy
400,613
+324,515
+426% +$6.23M ﹤0.01% 2512
2024
Q3
$1.47M Buy
76,098
+53,415
+235% +$984K ﹤0.01% 3974
2024
Q2
$372K Buy
22,683
+4,992
+28% +$77.4K ﹤0.01% 4786
2024
Q1
$270K Buy
+17,691
New +$278K ﹤0.01% 5201
2023
Q4
Sell
-375,136
Closed -$4.87M 6290
2023
Q3
$4.87M Sell
375,136
-657,469
-64% -$8.54M ﹤0.01% 2708
2023
Q2
$13.1M Sell
1,032,605
-73,207
-7% -$916K 0.01% 1753
2023
Q1
$12.4M Sell
1,105,812
-1,028,344
-48% -$12.5M 0.01% 1746
2022
Q4
$28.3M Sell
2,134,156
-369,816
-15% -$4.86M 0.02% 1164
2022
Q3
$29.1M Buy
2,503,972
+1,178,325
+89% +$16.2M 0.02% 1030
2022
Q2
$19.6M Buy
1,325,647
+149,102
+13% +$2.44M 0.01% 1332
2022
Q1
$22.8M Sell
1,176,545
-75,877
-6% -$1.36M 0.01% 1256
2021
Q4
$21.6M Sell
1,252,422
-44,688
-3% -$761K 0.01% 1370
2021
Q3
$21.7M Buy
1,297,110
+599,655
+86% +$8.97M 0.01% 1248
2021
Q2
$9.35M Buy
697,455
+683,575
+4,925% +$8.55M 0.01% 1996
2021
Q1
$166K Buy
+13,880
New +$168K ﹤0.01% 5554
2020
Q4
Sell
-71,438
Closed -$747 5384
2020
Q3
$747 Buy
+71,438
New +$908K ﹤0.01% 3335
2019
Q4
Sell
-422,266
Closed -$4.45M 4412
2019
Q3
$4.45M Buy
422,266
+399,551
+1,759% +$4.78M 0.01% 1904
2019
Q2
$331K Buy
+22,715
New +$322K ﹤0.01% 3490
2019
Q1
Sell
-324,698
Closed -$5.67M 4127
2018
Q4
$5.67M Buy
324,698
+234,439
+260% +$3.81M 0.01% 1501
2018
Q3
$1.38M Sell
90,259
-122,924
-58% -$1.77M ﹤0.01% 2685
2018
Q2
$2.94M Sell
213,183
-125,827
-37% -$1.89M ﹤0.01% 2152
2018
Q1
$5.65M Buy
339,010
+278,287
+458% +$4.3M 0.01% 1720
2017
Q4
$862K Sell
60,723
-623,048
-91% -$8.31M ﹤0.01% 2790
2017
Q3
$9.65M Buy
+683,771
New +$9.04M 0.01% 1270
2016
Q4
Sell
-468,921
Closed -$5.15M 3509
2016
Q3
$5.15M Sell
468,921
-106,402
-18% -$1.24M 0.01% 1322
2016
Q2
$6.06M Sell
575,323
-802,677
-58% -$9.5M 0.01% 1144
2016
Q1
$17.3M Buy
1,378,000
+1,112,174
+418% +$12.2M 0.04% 548
2015
Q4
$2.8M Sell
265,826
-562,400
-68% -$5.17M 0.01% 1719
2015
Q3
$5.95M Buy
828,226
+691,047
+504% +$9.39M 0.01% 1231
2015
Q2
$2.48M Buy
+137,179
New +$2.36M ﹤0.01% 1781
2015
Q1
Sell
-86,605
Closed -$1.23M 3830
2014
Q4
$1.23M Buy
86,605
+60,402
+231% +$908K ﹤0.01% 2350
2014
Q3
$448K Buy
+26,203
New +$602K ﹤0.01% 2807
2014
Q1
Sell
-420,591
Closed -$12.1M 3674
2013
Q4
$12.1M Buy
420,591
+34,295
+9% +$1M 0.04% 589
2013
Q3
$12.7M Buy
386,296
+324,246
+523% +$10.1M 0.04% 574
2013
Q2
$1.93M Buy
+62,050
New +$1.66M 0.01% 1609

Other funds holding INVA

Israel Englander's INVA Position: Q2 2026 in Review

Israel Englander increased its Innoviva (INVA) stake by 11% in Q2 2026, buying an estimated $5.99M and bringing the position to 2,541,109 shares worth $57.7M. The position accounts for 0.02% of the portfolio, ranked #813.

Israel Englander first reported a position in INVA in Q2 2013 and has held it in 41 quarters since. 307 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • Israel Englander held 2,541,109 shares of Innoviva worth $57.7M as of Q2 2026.
  • Israel Englander bought 261,658 Innoviva shares in Q2 2026, an estimated $5.99M.
  • Innoviva made up 0.02% of Israel Englander's portfolio in Q2 2026, its #813 holding.
  • Israel Englander first reported a position in Innoviva in Q2 2013 and has held it in 41 quarters since.
  • 307 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.